Magnetic resonance imaging offered a 29 percent higher sensitivity than CT for differentiating liver metastases, but CT provided 12 percent higher sensitivity than MRI for assessing vascular invasion, according to a new 40-study meta-analysis.
|Articles|November 6, 2002
PACS and storage firms team up
Merge eFilm has completed the integration of its PACSbuilder technology with EMC's Centera content addressed storage. Quantum Diagnostic Imaging of Dallas will be the first to implement the integrated system. PACSbuilder is designed to optimize workflow
Advertisement
Merge eFilm has completed the integration of its PACSbuilder technology with EMC's Centera content addressed storage. Quantum Diagnostic Imaging of Dallas will be the first to implement the integrated system. PACSbuilder is designed to optimize workflow throughout the healthcare enterprise, integrating database, image storage, and workflow capabilities. EMC's Centera supports archiving functions with a new software-driven storage architecture. The combination of PACSbuilder and Centera should provide an unprecedented amount of disk-based networked storage for rapid access to all types of radiological images, improving speed, performance, and efficiency, according to Merge eFilm.
Advertisement
Related to this article
In a recent interview with Diagnostic Imaging, Joseph Cavallo, MD, MBA, offered insights on post-deployment monitoring with AI, the potential for improved workflow efficiency and the ongoing challenge of balancing essential clinical skills and AI literacy in the training of radiology residents and fellows.
Does fractional flow reserve (FFR) or quantitative plaque burden from CCTA provide greater prognostic insight into coronary disease?
In the first of a three-part podcast episode, Wendie Berg, MD, PhD, FACR, FSBI, Manisha Bahl, MD, and Amy Patel, MD share insights on the utility of AI in breast imaging with respect to potential advantages, current concerns and future directions.
Catch up on the most-well viewed radiology content in September 2026.
The BiPASS program, which combines 68Ga PSMA PET imaging with prostate MRI prior to the use of prostate biopsy, is slated to be evaluated in an impending phase 3 trial.
For patients with localized prostate cancer, stereotactic body radiotherapy (SBRT) offered comparable freedom from biochemical/clinical failure at eight years and nearly 40 percent lower urinary incontinence in comparison to radical prostatectomy, according to research presented at the ASTRO conference.
Catch up on the most well-viewed video interviews from Diagnostic Imaging in September 2026.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
The Reading Room Podcast: Current Perspectives, Challenges and Possibilities with AI in Breast Imaging, Part 1
2
FDA Grants Fast Track Designation for Pre-Biopsy Use of PSMA PET and MRI for Prostate Cancer Detection
3
Current Perspectives on Integrating AI into Radiology
4
Radiology and Building the Alzheimer’s Care Pathway of the Future
5